ISO 10993-1-2018 医疗器械的生物评价第1部分:风险管理过程中的评价和测试(中英文版)

51zlzl 2025-11-20 9 994.76KB 73 页 300质量币
侵权投诉
ISO 10993-1:2018(E) 中英文版
INTERNATIONAL
STANDARD
Fifth edition
第5
2018-08
Biological evaluation of medical devices —Part
1:Evaluation and testing within a risk management
process
疗器械的1
()
202403
Reference number
ISO 10993-1:2018(E)
PAGE:1 CISO2018-Allrightsreserved
ISO 10993-1:2018(E) 中 英 文 版
目 录
Foreword .......................................................................................................................................................................................3
Introduction 介绍............................................................................................................................................................................. 5
1. Scope 范 围......................................................................................................................................................................................7
2. Normative references 范性引用文件 ................................................................................................................................. 8
3. Terms and definitions 术语及定义.................................................................................................................................... 9
4. General principles applying to biological evaluation of medical devices 医疗器械生物学评价的一般原则........... 15
5. Categorization of medical devices 医疗器械的分类....................................................................................................... 21
5.1. General 概述....................................................................................................................................................................... 21
5.2. Categorization by nature of body contact 按身体接触性质分类................................................................. 2
5.2.1. Non -contacting medical devices 非接触式医疗器械....................................................................................... 2
5.2.2. Surface -contacting medical devices 表面接触医疗器械............................................................................... 2
5.2.3. Externally communicating medical devices 外部接入医疗器械............................................................... 23
5.2.4. Implant medical devices 植入医疗器械......................................................................................................... 24
5.3. Categorization by duration of contact 按接触时间分......................................................................................25
5.3.1. Contact duration categories 接触时间分类.............................................................................................25
5.3.2. Transitory -contacting medical devices 时接触医疗器械............................................................... 25
5.3.3. Medical devices with multiple contact duration categories 种接触时间分类的医疗器械....... 26
6. Biological evaluation process 物学评价过程.......................................................................................................... 26
6.1. Physical and chemical information for biological risk analysis 生物学风险分析的物理和化学信息........... 26
6.2. Gap analysis and selection of biological endpoints for assessment 差距分析和生物学评估终点的选择...... 27
6.3. Biological testing 生物学测试.......................................................................................................................................28
6.3.1. General 概述............................................................................................................................................................... 28
6.3.2. Testing for evaluation 评估试验....................................................................................................................... 30
7. Interpretation of biological evaluation data and overallbiologicalrisk assessment
生物学评价数据的解释和生物风险的总体评估 ..........................................................................................................................18
Annex A (informative ) Endpoints to be addressed in a biological risk assessment
附 件A( 资 料 性) 生 物 学 风险 评 定 涉 及的 终 点 ....................................................................................................................... 40
Annex B (informative ) Guidance on the conduct of biological evaluation within a risk management process
B(资料性附录)关于在风险管理过程中进行生物学评价的指南.............................................................................45
Annex C (informative ) Suggested procedure for iterature review 附录C(资料性附录)建议的文献审查程序...... 68
Bibliography 考文.................................................................................................................................................................. 71
PAGE:2 CISO2018-Allrightsreserved
ISO 10993-1:2018(E)中英文版
Foreword
前言
ISO(the International Organization for Standardization)is a worldwide federation of national standards
bodies (ISO member bodies).The work of preparing International Standards is normally carried out
through ISO technical committees.Each member body interested in a subject for which a technical
committee has been established has the right to be represented on that committee.International
organizations,governmental and non-governmental,in liaison with ISO,also take part in the work.
ISO(国际标准化组织)是一个由国家标准机构(ISO 成员机构)组成的世界性联合会。编制国际标准的工作通常通
ISO技术委员行。对已技术委员主题感兴的每成员机构有权在该会中
非政
ISO collaborates closely with the International Electrotechnical Commission (IEC)on all matters of
electrotechnical standardization.
ISO与国际电工委员会(IEC) 在电工技术标准化事项上密作。
The procedures used to develop this document and those intended for its further maintenance are
described in the ISO/IEC Directives,Part 1.In particular the different approval criteria needed for the
different types of ISO documents should be noted.This document was drafted in accordance with the
editorial rules of the ISO/IEC Directives,Part 2 (see www .iso .org/directives).
ISO/IEC指令第1部分描述了用编制本文件的序以及用进一步维护的序。尤其注意不同类型ISO需的
不同批准标准。本文件是根ISO/IEC指令第2部分的编辑规则起草的(见www .iso .org/directives)。
Attention is drawn to the possibility that some of the elements of this document may be the subject of
patent rights.ISO shallnot be held responsible for identifying any or all such patent rights.Details of any
patent rights identified during the development of the document will be in the Introduction and/or on the
ISO list of patent declarations received (see www .iso .org/patents).
的某能是专利主题ISO 别任何或此类责任开发过程
确定的任何专利权的详细信息将在引言和/或收到的ISO专利声明列表中(见www .iso .org/patents)。
Any trade name used in this document is information given for the convenience of users and does not
constitute an endorsement.
使任何都是为了便可。
For an explanation on the voluntary nature of standards,the meaning of ISO specific terms and
expressions related to conformity assessment,as well as information about ISO's adherence to the World
Trade Organization (WTO)principles in the Technical Barriers to Trade(TBT)see the following URL:
www .iso .org/iso/foreword .html.
关于的自性质、与格评定相关的ISO特定术语和表达的含义,以ISO 守世界贸易组(WTO) 术性
易壁垒(TBT) 原则的信息,请参阅以下网址www .iso .org/iso/foreword .html
This document was prepared by Technical Committee ISO/TC 194,Biological and clinical evaluation of
medical devices.
PAGE:3 CISO2018-Allrightsreserved
摘要:

ISO10993-1:2018(E)中英文版INTERNATIONALSTANDARD国际标准Fifthedition第5版2018-08Biologicalevaluationofmedicaldevices—Part1:Evaluationandtestingwithinariskmanagementprocess医疗器械的生物评价第1部分:风险管理过程中的评价和测试(中英文版)2024年03月翻译ReferencenumberISO10993-1:2018(E)PAGE:1CISO2018-AllrightsreservedISO10993-1:2018(E)中英文版目录Foreword...

展开>> 收起<<
ISO 10993-1-2018 医疗器械的生物评价第1部分:风险管理过程中的评价和测试(中英文版).pdf

共73页,预览50页

还剩页未读, 继续阅读

声明:如果您的权利被侵害,请联系我们的进行举报。
作者: 51zlzl 分类:法规规范 价格:300质量币 属性:73 页 大小:994.76KB 格式:PDF 时间:2025-11-20
/ 73
客服
关注